On PharmTech.com this week, coverage of upcoming events continued, experts continued to discuss the use of AI in pharma, and validation in oral solid dosage product production was emphasized.
|Articles|June 24, 2015
Trends in Pharmaceutical Capsules
ACG Worldwide discusses current and future uses of capsules in a video interview with Pharmaceutical Technology.
Advertisement
Ajit Singh, chairman of ACG Worldwide, spoke with Pharmaceutical Technology at INTERPHEX 2015 about trends in pharmaceutical capsules. Innovations include printing on the capsule as an anticounterfeiting measure and use of additional physical forms, such as liquids and pastes, inside capsules. In the future, large-molecule, biological products could be found in capsules, Singh predicts.
Advertisement
Related to this article
Christy Owings, Thermo Fisher, on why early supply chain partnership and site visits prevent costly eCOA and clinical trial delays.
Christy Owings, Thermo Fisher, on how AI complements clinical supply chain expertise, streamlines site logistics, and tracks shifting biotech markets.
Christy Owings, Thermo Fisher, speaks on why importer of record strategy and vetted local partners are key to reliable clinical trial supply chains.
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol Myers Squibb, discuss navigating CMC requirements for new modalities and AI’s involvement in CMC.
Christy Owings, Thermo Fisher, discusses how customs delays and import complexity risk clinical trial supply chains in Latin America.
This week saw predictive modeling, microstructure intelligence, a CAR T-cell safety pause, and major licensing deals reshape pharma manufacturing.
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol Myers Squibb, discussed how CMC review practices are evolving and what that means for manufacturing strategy.
Advertisement
Advertisement